Concierge gives you timely BUY and SELL alerts on ASX-listed stocks
Emerging Stocks Down Under 11 May 2021: Kazia Therapeutics, Little Green Pharma, Eden Innovations
Kazia Therapeutics: Tackling glioblastoma
In today’s edition of Emerging Stocks Down Under, Sydney-based biotech Kazia Therapeutics is making waves in its treatment of rare brain cancers, including glioblastoma, one of the rarest, but most aggressive tumours. Despite the high morbidity rates associated with glioblastoma combined with limited available therapies, the company’s lead drug could help to address the unmet needs in existing brain cancer treatments.
Also in today’s edition, a look at medical cannabis producer the Little Green Pharma (ASX: LGP) and hydrogen technology developer Eden Innovations (ASX: EDE).
Click here to read the previous edition of Emerging Stocks Down Under published 4 May 2021